Added to YB: 2024-03-04
Pitch date: 2024-03-02
SRX.AX [bullish]
Sirtex Medical Pty Ltd.
Author Info
Company Info
Sirtex Medical Pty Ltd manufactures and distributes liver cancer treatments utilizing small particle technology in North America, Australia, New Zealand, Asia, Europe, and Latin America.
Market Cap
AUD 1.9B
Pitch Price
N/A
Price Target
0.20 (-99%)
Dividend
N/A
EV/EBITDA
N/A
P/E
45.96
EV/Sales
N/A
Sector
Biotechnology
Category
value
Sierra Rutile Holdings Limited - $SRX.AX
SRX.AX: Market cap halved to $30M amid rutile price drop, rising costs, political instability & tax changes in Sierra Leone, forcing production halt from Mar '24. But ~$61M cash & working capital (Dec '23) after ~$24-29M liabilities & wind-down costs could yield ~$70M value (2x current price). Risks: receivables & inventory concerns, but sales to reputable TiO2 firms & Europe inventory storage manageable. Attractive risk/reward despite uncertainties.
Read full article (4 min)